Rockefeller Capital Management
MIRM icon

Rockefeller Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Rockefeller Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$413K Sell
4,835
-53
-1% -$5.53K ﹤0.01% 2236
2026
Q2 		$572K Buy
4,888
+17
+0.3% +$1.71K ﹤0.01% 2016
2026
Q1 		$450K Buy
4,871
+3,189
+190% +$300K ﹤0.01% 2028
2025
Q4 		$133K Buy
1,682
+1,158
+221% +$83.1K ﹤0.01% 2574
2025
Q3 		$38.4K Buy
+524
New +$33.3K ﹤0.01% 3036

Other funds holding MIRM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Rockefeller Capital Management's MIRM Position: Q3 2026 in Review

Rockefeller Capital Management reduced its Mirum Pharmaceuticals (MIRM) stake by 1.1% in Q3 2026, selling an estimated $5.53K and leaving 4,835 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #2236.

Rockefeller Capital Management first reported a position in MIRM in Q3 2025 and has held it in 5 quarters since. The position peaked at $572K in Q2 2026. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Rockefeller Capital Management held 4,835 shares of Mirum Pharmaceuticals worth $413K as of Q3 2026.
  • Rockefeller Capital Management sold 53 Mirum Pharmaceuticals shares in Q3 2026, an estimated $5.53K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #2236 holding.
  • Rockefeller Capital Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Rockefeller Capital Management's Mirum Pharmaceuticals position peaked at $572K in Q2 2026.
  • 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.